EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Steven P,Angus

第一单位： Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

作者： Steven P,Angus ^[1] ; Janet L,Oblinger ^[2] ; Timothy J,Stuhlmiller ^[1] ; Patrick A,DeSouza ^[3] ; Roberta L,Beauchamp ^[3] ; Luke,Witt ^[3] ; Xin,Chen ^[1] ; Justin T,Jordan ^[4] ; Thomas S K,Gilbert ^[1] ; Anat,Stemmer-Rachamimov ^[5] ; James F,Gusella ^[6] ; Scott R,Plotkin ^[4] ; Stephen J,Haggarty ^[6] ; Long-Sheng,Chang ^[2] ; Gary L,Johnson ^[1] ; Vijaya,Ramesh ^[6] ; Children’s Tumor Foundation Synodos for NF2 Consortium

作者单位： Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina. ^[1] Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children's Hospital.;Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio. ^[2] Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts. ^[3] Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts. ^[4] Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts. ^[5] Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts.;Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts. ^[6]